Special Review Decision SRD2021-02, Special Review Decision: Linuron and Its Associated End-use Products

This document presents the final regulatory decision for the special review of linuron. A reference list of information used as the basis for the proposed special review decision is included in PSRD2020-05. Therefore, the complete reference list of all information used in this final special review decision includes the information set out in PSRD2020-05.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-05-31

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data